Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

New faces at Baxter: Karenann Terrell will assume the role of chief information officer April 10, replacing John Moon, who held the position for six years but left to pursue other opportunities, according to the firm. Terrell joins Baxter from a six-year stint with DaimlerChrysler. Baxter also will be joined by new VP-Human Resources Jeanne Mason on May 15, filling the vacancy created last fall when Karen May left for Kraft Foods. Mason spent 18 years at General Electric, most recently at GE Insurance Solutions. Cheryl White became Baxter's permanent VP-quality March 29. She has filled the role on an interim basis since Lawrence Gibbons left the company in November (1"The Gray Sheet" Nov. 28, 2005, p. 11)...

You may also be interested in...



AdvaMed Posts Guidelines For Pacemaker And ICD Performance Reports

Representatives of implantable defibrillator and pacemaker manufacturers are recommending that companies standardize their product performance reports and present data in a way that is more useful to physicians

People In Brief

CoreValve gets reg affairs in order: Kalathi Thyagarajan, PhD, joins as VP-regulatory affairs & quality assurance. Thyagarajan, who has consulted for CoreValve since June, will be tasked with securing ISO certification of Irvine, Calif.-based CoreValve USA and managing the clinical trial for the ReValving percutaneous aortic valve system to support European regulatory approval. He is also responsible for interacting with FDA. Previously, Thyagarajan served in senior research and regulatory management roles at cardiac implant start-ups 3F Therapeutics and VenPro. He also worked at Edwards Lifesciences before its spin-off from Baxter in 2000. CoreValve recently said it may go public in 2007 (1"The Gray Sheet" Nov. 21, 2005, p. 17)...

Financings In Brief

Adiana: Non-incisional, permanent contraceptive manufacturer will use the proceeds from a $23 mil. Series D financing to complete its pivotal clinical trial, obtain PMA approval and prepare for market launch. The funding was led by Tullis-Dickerson & Co., with OrbiMed Advisors LLC joining as a new investor. Both venture capital firms will be represented on the firm's board of directors, according to Adiana. The company expects to pursue a PMA for the device in early 2006, after completing a 600-patient, 16-site clinical trial. Once approved, Adiana will compete with Conceptus' Essure non-incisional permanent birth-control device(1"The Gray Sheet" Dec. 6, 2004, p. 24)...

Related Content

UsernamePublicRestriction

Register

MT023424

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel